Xiamen Amoytop Biotech Co., Ltd.
Clinical trials sponsored by Xiamen Amoytop Biotech Co., Ltd., explained in plain language.
-
Weekly shot could replace daily injections for growth-stunted kids
Disease control Recruiting nowThis study tests whether a once-weekly injection of a new growth hormone (inpegsomatropin) works as well as the standard daily growth hormone shot in children who were born small for their age and remain very short. About 141 prepubertal children will receive one of two doses of …
Phase: PHASE3 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New hope for rare blood cancer patients: experimental drug targets uncontrolled platelet counts
Disease control Recruiting nowThis study tests two doses of peginterferon alfa-2b in 27 adults with essential thrombocythemia, a rare blood cancer causing too many platelets. Participants have not responded well to or cannot tolerate the standard drug hydroxyurea. The goal is to see which dose works better an…
Phase: PHASE2 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC